文化大學機構典藏 CCUR:Item 987654321/44641
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 47250/51116 (92%)
Visitors : 14594745      Online Users : 1558
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/44641


    Title: Safe Nanocomposite-Mediated Efficient Delivery of MicroRNA Plasmids for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Therapy
    Authors: Tsai, YC (Tsai, Yen-Chang)
    Teng, IL (Teng, I-Ling)
    Jiang, SS (Jiang, Si-Tse)
    Lee, YC (Lee, Yi-Che)
    Chiou, YY (Chiou, Yuan-Yow)
    Cheng, FY (Cheng, Fong-Yu)
    Contributors: 化學系
    Keywords: DNA DELIVERY
    LIPID NANOPARTICLES
    TRANSGENIC MICE
    ANTI-MIRNA
    EXPRESSION
    OVEREXPRESSION
    PROGRESSION
    PROTEIN
    MOUSE
    Date: 2019-05-07
    Issue Date: 2019-06-25 12:48:02 (UTC+8)
    Abstract: There is currently no cure for gene mutation-caused autosomal dominant polycystic kidney disease (ADPKD). Over half of patients with ADPKD eventually develop kidney failure, requiring dialysis or kidney transplantation. Current treatment modalities for ADPKD focus on reducing morbidity and mortality from renal and extrarenal complications of the disease. MicroRNA has been shown to be useful in treating ADPKD. This study combines anti-miR NA plasmids and iron oxide/alginate nanoparticles for conjugation with antikidney antibodies. These nanocomposites can specifically target renal tubular cells, providing a potential treatment for ADPKD. Magnetic resonance imaging and in vivo imaging system results show effective targeting of renal cells. Anti-miRNA plasmids released from the nanocomposites inhibit cell proliferation and cyst formation in the PKD cellular and animal models. The results suggest the novel combination of the anti-miRNA plasmids and nanomaterials provides potential clinical implications for ADPKD treatment.
    Relation: Advanced Healthcare Materials
    Volume8, Issue5 March 7, 2019 1801358
    Appears in Collections:[Department of Chemistry & Graduate Institute of Applied Chemistry ] journal articles

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML272View/Open


    All items in CCUR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©  2006-2025  - Feedback